RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
4.820
-0.280 (-5.49%)
At close: Jun 30, 2026, 4:00 PM EDT
4.910
+0.090 (1.87%)
After-hours: Jun 30, 2026, 7:55 PM EDT
RxSight Market Cap
RxSight has a market cap or net worth of $199.53 million as of June 30, 2026. Its market cap has decreased by -65.45% in one year.
Market Cap
199.53M
Enterprise Value
-7.52M
1-Year Change
-65.45%
Ranking
Category
Stock Price
$4.82
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $199.53M, a decrease of -52.98%. That is a compound annual growth rate of -14.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 199.53M | -53.43% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
| Jul 30, 2021 | 424.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senseonics Holdings | 298.60M |
| TriSalus Life Sciences | 290.50M |
| Treace Medical Concepts | 289.33M |
| Standard BioTools | 286.61M |
| Profound Medical | 239.20M |
| Lucid Diagnostics | 206.03M |
| Quanterix | 203.50M |
| InfuSystem Holdings | 202.83M |